Casdin Capital, LLC Legend Biotech Corp Transaction History

Casdin Capital, LLC

  • $1.29 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$25.8 - $32.39 $3.6 Million - $4.52 Million
-139,661 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$27.5 - $39.61 $128,177 - $184,622
4,661 Added 3.45%
139,661 $4.31 Million
Q2 2020

Aug 14, 2020
BUY
$36.1 - $42.56 $4.87 Million - $5.75 Million
135,000 New
135,000 $5.75 Million

Others Institutions Holding LEGN

# of Institutions
225
Shares Held
74.3M
Call Options Held
279K
Put Options Held
350K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email